Literature DB >> 15090421

Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus.

K Probst1, R Fijnheer, P Schellekens, A Rothova.   

Abstract

AIMS: To determine intraocular and plasma levels of cellular fibronectin (cFN) in patients with uveitis or diabetes mellitus (DM) and to assess the association with disease activity, macular oedema, and vascular leakage on fluorescein angiography. In addition, to examine whether cFN is locally produced in the eye.
METHODS: Intraocular and plasma levels of cFN were determined by ELISA in 39 patients with uveitis (23 active, 16 non-active), in 11 patients with DM (eight with and three without diabetic retinopathy) and in 17 control patients. The influence of diabetic retinopathy, inflammatory activity, vascular leakage, and macular oedema (MO) on intraocular and plasma cFN levels was studied. Local production of cFN was determined by calculating absolute and relative intraocular to plasma ratios. Aqueous and vitreous levels of cFN were compared.
RESULTS: No differences in plasma cFN levels were found between patients with uveitis, DM, or controls. Intraocular cFN levels were significantly raised in patients with uveitis and DM, specifically in those with active disease (active uveitis and active diabetic retinopathy versus controls: p = 0.001 and 0.002 respectively). Further, intraocular cFN levels were significantly elevated in patients with macular oedema or vascular leakage, irrespectively of whether associated with uveitis or DM (p = 0.001 and 0.002). Intraocular cFN levels were consistently higher in the vitreous than the aqueous. Intraocular production of cFN was documented by elevated absolute and relative intraocular to plasma ratios in nine out of 11 patients tested.
CONCLUSIONS: Elevated intraocular cFN levels were found in uveitis and DM, especially in those with active processes, intraocular vascular damage, and MO. These results suggest that locally produced cFN levels reflect intraocular vascular damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090421      PMCID: PMC1772136          DOI: 10.1136/bjo.2003.026542

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  44 in total

Review 1.  Fibronectin: structure, assembly, and cardiovascular implications.

Authors:  M K Magnusson; D F Mosher
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

2.  Basement membrane abnormalities in human eyes with diabetic retinopathy.

Authors:  A V Ljubimov; R E Burgeson; R J Butkowski; J R Couchman; L Zardi; Y Ninomiya; Y Sado; Z S Huang; A B Nesburn; M C Kenney
Journal:  J Histochem Cytochem       Date:  1996-12       Impact factor: 2.479

3.  Cellular and plasma fibronectin in the aqueous humour of primary open-angle glaucoma, exfoliative glaucoma and cataract patients.

Authors:  M Vesaluoma; P Mertaniemi; S Mannonen; I Lehto; R Uusitalo; S Sarna; A Tarkkanen; T Tervo
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

4.  Homologous serum-stimulated fibronectin synthesis in human retinal pigmented epithelial cells.

Authors:  S Z Stocks; I A Shiels; S M Taylor
Journal:  Aust N Z J Ophthalmol       Date:  1999 Jun-Aug

5.  [Immunohistologic studies of the vitreous humor].

Authors:  S Dunker; R Kleinert; J Faulborn
Journal:  Ophthalmologe       Date:  1998-01       Impact factor: 1.059

6.  Diagnostic anterior chamber paracentesis in uveitis: a safe procedure?

Authors:  A Van der Lelij; A Rothova
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

Review 7.  The fibronectin gene as a model for splicing and transcription studies.

Authors:  A R Kornblihtt; C G Pesce; C R Alonso; P Cramer; A Srebrow; S Werbajh; A F Muro
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

8.  Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis.

Authors:  J H de Boer; C Verhagen; M Bruinenberg; A Rothova; P T de Jong; G S Baarsma; A Van der Lelij; F M Ooyman; J G Bollemeijer; P J Derhaag; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1996-06       Impact factor: 5.258

9.  Analysis of extracellular matrix synthesis during wound healing of retinal pigment epithelial cells.

Authors:  M Kamei; A Kawasaki; Y Tano
Journal:  Microsc Res Tech       Date:  1998-09-01       Impact factor: 2.769

10.  Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.

Authors:  B Kenarova; L Voinov; C Apostolov; R Vladimirova; A Misheva
Journal:  Eur J Ophthalmol       Date:  1997 Jan-Mar       Impact factor: 1.922

View more
  4 in total

1.  Impact of fibronectin on surface properties of intraocular lenses.

Authors:  Andreas C Schroeder; Christian Lingenfelder; Berthold Seitz; Udo Grabowy; Christoph W Spraul; Zisis Gatzioufas; Mathias Herrmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-04       Impact factor: 3.117

2.  Human apolipoprotein(a) kringle V inhibits ischemia-induced retinal neovascularization via suppression of fibronectin-mediated angiogenesis.

Authors:  Yangmi Lim; Dong Hyun Jo; Jin Hyoung Kim; Jin-Hyung Ahn; Yu Kyeong Hwang; Dong-Ku Kang; Soo-Ik Chang; Young Suk Yu; Yeup Yoon; Jeong Hun Kim
Journal:  Diabetes       Date:  2012-03-16       Impact factor: 9.461

3.  Mesenchymal marker expression is elevated in Müller cells exposed to high glucose and in animal models of diabetic retinopathy.

Authors:  Ti Zhou; Di Che; Yuqing Lan; Zhenzhen Fang; Jinye Xie; HaiJun Gong; ChaoYang Li; Juan Feng; Honghai Hong; Weiwei Qi; Caiqi Ma; Zhonghan Yang; WeiBin Cai; Jun Zhong; Jianxing Ma; Xia Yang; Guoquan Gao
Journal:  Oncotarget       Date:  2017-01-17

Review 4.  Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.

Authors:  Binapani Mahaling; Shermaine W Y Low; Molly Beck; Devesh Kumar; Simrah Ahmed; Thomas B Connor; Baseer Ahmad; Shyam S Chaurasia
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.